Mon panier

IL-12 R beta 1

IL-12 R beta 1 Informations sur la molécule

Nom anglaisInterleukin-12 receptorNombre de médicaments commercialisés0
Nombre de médicaments cliniques9Alias de la cibleReceptors, Interleukin-12
Phase de R&D la plus avancéePhase 2 Clinical
Nom anglaisInterleukin-12 receptor
Alias de la cibleReceptors, Interleukin-12
Nombre de médicaments commercialisés0
Nombre de médicaments cliniques9
Phase de R&D la plus avancéePhase 2 Clinical

IL-12 R beta 1 Liste de produits

  • Attribut

    Protein (7)

  • Bibliothèque de produits

    En ligne (7)

  • Espèces

    Human (4)Cynomolgus (2)Mouse (1)

  • Étiquette

    His Tag (1)Fc Tag & Avi Tag (1)Fc Tag (2)His Tag & Avi Tag (3)

  • Marqueur

    Unconjugated (3)Biotin-labeled (4)

IL-12 R beta 1Contexte de la molécule

The human IL-12 R subunit is a member of the cytokine receptor superfamily and the functional high-affinity IL-12R is composed of at least two beta-type cytokine receptor subunits, each independently exhibiting a low affinity for IL-12. IL-12 R beta 1 (Interleukin-12 receptor subunit beta-1) is also known as IL-12RB1, CD212. Functions as an interleukin receptor which binds interleukin-12 with low affinity and is involved in IL12 transduction. Associated with IL12RB2 it forms a functional, high affinity receptor for IL12. Associates also with IL23R to form the interleukin-23 receptor which functions in IL23 signal transduction probably through activation of the Jak-Stat signaling cascade.

IL-12 R beta 1Alias de la molécule

IL-12 R beta 1,IL12RB1,CD212,IL12R,IL12RB,IL-12RB1

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
KLT-1101KLT-1101Phase 2 ClinicalKang Litai Pharmaceutical Co LtdLeukopenia; Melanoma; Sarcoma, Kaposi; Solid tumours; Thrombocytopenia
Details
Edodekin alfaRO 247472; YM 01CPhase 2 ClinicalF. Hoffmann-La Roche Ltd, Valeant, Wistar InstituteAbdominal Neoplasms; Asthma; Bacterial Infections; Breast Neoplasms; Carcinoma, Ovarian Epithelial; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Graft vs Host Disease; Hepatitis B; Hepatitis C; HIV Infections; Leishmaniasis; Lymphoma; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Malaria; Melanoma; Neoplasms; Sarcoma, Kaposi; Solid tumours; Squamous Cell Carcinoma of Head and Neck
Details
RTX-224RTX-224Phase 2 ClinicalRubius Therapeutics IncCarcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Skin Melanoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms
Details
KB-707KB707; KB-707Phase 2 ClinicalKrystal Biotech IncCarcinoma, Non-Small-Cell Lung; Lung Neoplasms; Melanoma; Neoplasms; Skin Melanoma; Solid tumours
Details
ASP-9801ASP-9801Phase 1 ClinicalAstellas Pharma IncNeoplasm Metastasis; Neoplasms; Solid tumours
Details
Tolododekin AlfaANK101; ANK-101Phase 1 ClinicalAnkyra Therapeutics IncCarcinoma, Basosquamous; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Rejection of renal transplantation; Skin Neoplasms; Soft Tissue Injuries; Solid tumours
Details
CLN-617CLN-617Phase 1 ClinicalCullinan Therapeutics IncSolid tumours
Details
SON-1010SON-1010Phase 1 ClinicalSonnet Biotherapeutics IncCarcinoma, Ovarian Epithelial; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Sarcoma; Solid tumours
Details
phIL12 GETPhase 1 ClinicalInstitute Of Oncology LjubljanaCarcinoma, Basal Cell
Details

Avis sur les produits

  • K***n2024-10-05
    0Mettre un like
    I’ve been using the IL12 receptor protein from Acro Biosystem in my antibody discovery research, and I’m highly satisfied with its quality. The protein exhibits excellent stability and bioactivity, which has been crucial in my experiments targeting immune responses. It’s been a reliable reagent, showing consistent results across various assays. I highly recommend this product for anyone involved in immunological research, particularly in therapeutic antibody development.
  • Informations sur la molécule
  • Liste de produits
  • Avis sur les produits
  • Informations sur les médicaments cliniques